株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

静脈瘤治療市場:製品別(高周波アブレーションデバイス、レーザーアブレーションデバイス、その他)、治療別(硬化療法、静脈内アブレーション、その他)、地域別の予測

Varicose Vein Treatment Market - Forecast (2020 - 2025)

発行 IndustryARC 商品コード 422786
出版日 ページ情報 英文 116 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
静脈瘤治療市場:製品別(高周波アブレーションデバイス、レーザーアブレーションデバイス、その他)、治療別(硬化療法、静脈内アブレーション、その他)、地域別の予測 Varicose Vein Treatment Market - Forecast (2020 - 2025)
出版日: 2020年03月11日 ページ情報: 英文 116 Pages
概要

当レポートでは、世界の静脈瘤治療市場について調査し、市場の現状と将来見通し、製品別、治療別、地域別動向、市場に参入する主要企業のプロファイルなどをまとめています。

第1章 概要

第2章 エグゼクティブサマリー

第3章 市況

  • 市場シェア分析
  • 競合分析
  • 製品ベンチマーキング
  • エンドユーザープロファイリング
  • 主要5社の財務分析

第4章 市場の力

  • 促進因子
  • 阻害因子
  • 機会
  • 課題
  • ポーターズファイブフォース分析

第5章 戦略的分析

  • バリューチェーン分析
  • 価格分析
  • 機会分析
  • 製品/市場ライフサイクル分析
  • 供給者と販売業者

第6章 製品別市場

  • 高周波アブレーションデバイス
  • レーザーアブレーションデバイス
  • 静脈閉鎖製品
  • 外科製品

第7章 治療別市場

  • 硬化療法
  • 静脈内アブレーション
  • ストリッピング
  • レーザー
  • 高周波アブレーション

第8章 地域別市場

  • 欧州
  • アジア太平洋地域
  • 北米
  • その他

第9章 エントロピー

  • 拡充
  • 技術発展
  • 合併・買収、合弁
  • 供給契約

第10章 企業プロファイル

第11章 付録

目次
Product Code: HCR 0712

Varicose Vein Treatment market Overview:

Varicose Vein is a vein disorder where the veins gnarled and enlarged. The varicose veins generally appear in the lower limbs of the human body. The varicose vein treatment market consists of various treatment procedures such as radiofrequency ablation, laser therapy and so on. The global varicose vein treatment market is growing at CAGR 5.09% and the global market revenue is $ 325 million in 2018 and it is forecasted to reach $ 416 million by 2023.

Varicose Vein Treatment market Outlook:

Varicose veins are caused when the veins in the lower limbs do not allow the blood flow effectively. This condition in veins cause swelling, aching and pain in legs. Varicose veins can be classified into trunk varicose veins, reticular varicose veins and telangiectasia varicose veins. The treatment for varicose veins can be given in various methods like radiofrequency ability, laser therapy and sclerotherapy. . The end users for varicose vein treatment market are segmented as surgery centers and hospitals.

Varicose Vein Treatment market Growth drivers:

One of the major drivers in this industry is the prevalence of varicose veins is high in women. It is more common in older women. The risk of having varicose veins is more in pregnant women and in women who take menopausal hormone therapy. It is reported that women have twice the risk of having varicose veins when compared to men.

Varicose Vein Treatment market Challenges:

The major challenge in this industry is neovascularization, a process where regrowth of veins takes place. There are chances that even after a surgery, the varicose veins might regrow. Sometimes varicose veins might develop in other parts of the legs.

Varicose Vein Treatment market Research Scope:

The base year of the study is 2017, with forecast done up to 2023. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the Varicose Vein Treatment market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats.

Varicose Vein Treatment (SAP) Market Report: Industry Coverage:

Varicose Vein Treatment market - By treatment Types: surgical treatments: Vein ligation and stripping, phlebectomy; non-surgical treatments: Laser Therapy, trans-illuminated powered phebectomy (trivex), Radiofrequency ablation; Sclerotherapy.

Varicose Vein Treatment market - By Device: Ablation devices: Radiofrequency Ablation Devices, Laser Ablation Devices; Venous Closure Products, Surgical Products.

Varicose Vein Treatment market - By End-User industry: Healthcare Industry: Surgery centers, Hospitals: Specialty hospitals, Multispecialty hospitals

The Varicose Vein Treatment market report also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

North America: The U.S., Canada, Mexico

South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

Middle East and Africa: Israel, South Africa, Saudi Arabia

Varicose Vein Treatment market Key Players Perspective:

Some of the Key players in this market are Angiodynamics Inc, Biolitec AG, BTG Plc, Energist Medical Solutions, Eufoton S.R.L, Lumenis Ltd, Medtronic Inc., Quanta System S.p.A, Syneron Medical Ltd, and Vascular Solutions Inc. among others.

Market Research and Market Trends of Varicose Vein Treatment market:

Syneron Candela has been acquired by Apax partners. The Israel based non-surgical aesthetic device manufacturer has become a private company after its acquisition by an affiliate by funds for $11.00 per share was advised by Apax partners. It is reported that the transaction for acquiring Syneron candela was valued at approximately $400 million. This acquisition expands Apax Partners' investments in Healthcare industry.

Biolitec GmbH has launched a laser therapy product named LEONARDO mini and it is reported that this product can carry out laser treatment for varicose veins. The product weighs only 900 grams and it is available in two wavelengths (980nm and 1470nm).

BTG plc has acquired Novate medical ltd, a medical device manufacturer. BTG plc has paid $20 million in cash and it might be required to pay additional cash considerations up to $130 million if few commercial and sales related milestones are met.

Health Canada has approved Varithena, a drug and device combination product used to treat varicose veins. The product from BTG plc is intended to treat venous reflux. Varithena consists of polidocanol injectable foam.

1. Varicose Vein Treatment Market - Overview

  • 1.1. Definitions and Scope

2. Varicose Vein Treatment Market - Executive summary

  • 2.1. Market Revenue, Market Size and Key Trends by Company
  • 2.2. Key Trends by type of Application
  • 2.3. Key Trends segmented by Geography

3. Varicose Vein Treatment Market

  • 3.1. Comparative analysis
    • 3.1.1. Product Benchmarking - Top 10 companies
    • 3.1.2. Top 5 Financials Analysis
    • 3.1.3. Market Value split by Top 10 companies
    • 3.1.4. Patent Analysis - Top 10 companies
    • 3.1.5. Pricing Analysis

4. Varicose Vein Treatment Market Forces

  • 4.1. Drivers
  • 4.2. Constraints
  • 4.3. Challenges
  • 4.4. Porters five force model
    • 4.4.1. Bargaining power of suppliers
    • 4.4.2. Bargaining powers of customers
    • 4.4.3. Threat of new entrants
    • 4.4.4. Rivalry among existing players
    • 4.4.5. Threat of substitutes

5. Varicose Vein Treatment Market -Strategic analysis

  • 5.1. Value chain analysis
  • 5.2. Opportunities analysis
  • 5.3. Product life cycle

6. Varicose Vein Treatment Market- By medical procedure (Market Size -$Million / $Billion)

  • 6.1. Segment type Size and Market Share Analysis
  • 6.2. Application Revenue and Trends by type of Application
  • 6.3. Product Segment Analysis by Type
    • 6.3.1. Surgical treatments
      • 6.3.1.1. Vein ligation and stripping
      • 6.3.1.2. Phlebectomy
    • 6.3.2. Non-surgical treatments
      • 6.3.2.1. Laser Therapy
      • 6.3.2.2. transilluminated powered phebectomy(trivex)
      • 6.3.2.3. Radiofrequency ablation
    • 6.3.3. Sclerotherapy

7. Varicose Vein Treatment Market- By product based treatments (Market Size -$Million / $Billion)

  • 7.1. Ablation devices
    • 7.1.1. Radiofrequency Ablation Devices
    • 7.1.2. Laser Ablation Devices
  • 7.2. Venous Closure Products
  • 7.3. Surgical Products

8. Varicose Vein Treatment Market - By End User Industry (Market Size -$Million / $Billion)

  • 8.1. Market Size and Market Share Analysis
  • 8.2. Application Revenue and Trend Research
  • 8.3. Product Segment Analysis
    • 8.3.1. Healthcare industry
      • 8.3.1.1. Surgery centers
      • 8.3.1.2. Hospitals
      • 8.3.1.2.1. Specialty hospitals
      • 8.3.1.2.2. Multispecialty hospitals

9. Varicose Vein Treatment - By Geography (Market Size -$Million / $Billion)

  • 9.1. Varicose Vein Treatment Market - North America Segment Research
  • 9.2. North America Market Research (Million / $Billion)
    • 9.2.1. Segment type Size and Market Size Analysis
    • 9.2.2. Revenue and Trends
    • 9.2.3. Application Revenue and Trends by type of Application
    • 9.2.4. Company Revenue and Product Analysis
    • 9.2.5. North America Product type and Application Market Size
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
      • 9.2.5.4. Rest of North America
  • 9.3. Varicose Vein Treatment - South America Segment Research
  • 9.4. South America Market Research (Market Size -$Million / $Billion)
    • 9.4.1. Segment type Size and Market Size Analysis
    • 9.4.2. Revenue and Trends
    • 9.4.3. Application Revenue and Trends by type of Application
    • 9.4.4. Company Revenue and Product Analysis
    • 9.4.5. South America Product type and Application Market Size
      • 9.4.5.1. Brazil
      • 9.4.5.2. Venezuela
      • 9.4.5.3. Argentina
      • 9.4.5.4. Ecuador
      • 9.4.5.5. Peru
      • 9.4.5.6. Colombia
      • 9.4.5.7. Costa Rica
      • 9.4.5.8. Rest of South America
  • 9.5. Varicose Vein Treatment - Europe Segment Research
  • 9.6. Europe Market Research (Market Size -$Million / $Billion)
    • 9.6.1. Segment type Size and Market Size Analysis
    • 9.6.2. Revenue and Trends
    • 9.6.3. Application Revenue and Trends by type of Application
    • 9.6.4. Company Revenue and Product Analysis
    • 9.6.5. Europe Segment Product type and Application Market Size
      • 9.6.5.1. U.K
      • 9.6.5.2. Germany
      • 9.6.5.3. Italy
      • 9.6.5.4. France
      • 9.6.5.5. Netherlands
      • 9.6.5.6. Belgium
      • 9.6.5.7. Spain
      • 9.6.5.8. Denmark
      • 9.6.5.9. Rest of Europe
  • 9.7. Varicose Vein Treatment - APAC Segment Research
  • 9.8. APAC Market Research (Market Size -$Million / $Billion)
    • 9.8.1. Segment type Size and Market Size Analysis
    • 9.8.2. Revenue and Trends
    • 9.8.3. Application Revenue and Trends by type of Application
    • 9.8.4. Company Revenue and Product Analysis
    • 9.8.5. APAC Segment - Product type and Application Market Size
      • 9.8.5.1. China
      • 9.8.5.2. Australia
      • 9.8.5.3. Japan
      • 9.8.5.4. South Korea
      • 9.8.5.5. India
      • 9.8.5.6. Taiwan
      • 9.8.5.7. Malaysia

10. Varicose Vein Treatment Market - Entropy

  • 10.1. New product launches
  • 10.2. M&A's, collaborations, JVs and partnerships

11. Varicose Vein Treatment Market Company Analysis

  • 11.1. Market Share, Company Revenue, Products, M&A, Developments
  • 11.2. Angiodynamics Inc
  • 11.3. Biolitec AG
  • 11.4. BTG Plc
  • 11.5. Energist Medical Solutions
  • 11.6. Eufoton S.R.L
  • 11.7. Lumenis Ltd
  • 11.8. Medtronic Inc.
  • 11.9. Quanta System S.p.A
  • 11.10. Syneron Medical Ltd
  • 11.11. Vascular Solutions Inc.
  • 11.12. Company 11
  • 11.11. Company 12
  • 11.12. Company 11 and more

"*Financials would be provided on a best efforts basis for private companies"

12. Varicose Vein Treatment Market -Appendix

  • 12.1. Abbreviations
  • 12.2. Sources